Alice
Lv3
380 积分
2023-01-16 加入
-
Fgf10: a paracrine-signaling molecule in development, disease, and regenerative medicine
8天前
已完结
-
Prevention and treatment of FGFR inhibitor-associated toxicities
19天前
已完结
-
Implications of Fibroblast Growth Factors (FGFs) in Cancer: From Prognostic to Therapeutic Applications
20天前
已完结
-
Targeted Agents in Esophagogastric Cancer Beyond Human Epidermal Growth Factor Receptor-2
21天前
已完结
-
New therapeutic target molecules for gastric and gastroesophageal junction cancer
22天前
已完结
-
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
1个月前
已完结
-
Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1–2 trial
1个月前
已完结
-
Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive gastric cancer: a dose-expansion, phase 1 study
1个月前
已关闭
-
Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive gastric cancer: a dose-expansion, phase 1 study
1个月前
已完结
-
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
2个月前
已完结